Related references
Note: Only part of the references are listed.Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients
Hirotaka Fudaba et al.
SCIENTIFIC REPORTS (2021)
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer
Jiao Hu et al.
THERANOSTICS (2021)
Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways
Yu Yuan et al.
FRONTIERS IN PHARMACOLOGY (2020)
Siglec-15-targeting therapy protects against glucocorticoid-induced osteoporosis of growing skeleton in juvenile rats
Dai Sato et al.
BONE (2020)
Siglec-15 on Osteoclasts Is Crucial for Bone Erosion in Serum-Transfer Arthritis
Marina A. Korn et al.
JOURNAL OF IMMUNOLOGY (2020)
Glucocorticoid-Induced Osteoporosis: Why Kids Are Different
Leanne M. Ward
FRONTIERS IN ENDOCRINOLOGY (2020)
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang et al.
NATURE MEDICINE (2019)
Breast cancer cells expressing cancer-associated sialyl-Tn antigen have less capacity to develop osteolytic lesions in a mouse model of skeletal colonization
Ryo Fujita et al.
CLINICAL & EXPERIMENTAL METASTASIS (2019)
HACE1 is a potential tumor suppressor in osteosarcoma
Amal M. El-Naggar et al.
CELL DEATH & DISEASE (2019)
Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins
Kim F. Bornhoefft et al.
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY (2018)
Bone remodeling: A tissue-level process emerging from cell-level molecular algorithms
Clemente F. Arias et al.
PLOS ONE (2018)
Osteoblast-osteoclast interactions
Xiao Chen et al.
CONNECTIVE TISSUE RESEARCH (2018)
Identification of Siglec Ligands Using a Proximity Labeling Method
Lanyi Chang et al.
JOURNAL OF PROTEOME RESEARCH (2017)
The Role of Sialyl-Tn in Cancer
Jennifer Munkley
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Structural basis of myelin-associated glycoprotein adhesion and signalling
Matti F. Pronker et al.
NATURE COMMUNICATIONS (2016)
Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy
Yu Zhang et al.
JAMA ONCOLOGY (2016)
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) mediates periarticular bone loss, but not joint destruction, in murine antigen-induced arthritis
Tomohiro Shimizu et al.
BONE (2015)
Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis
Yusuke Kameda et al.
BONE (2015)
Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption
Matthew Stuible et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Impaired osteoclast differentiation and function and mild osteopetrosis development in Siglec-15-deficient mice
Yoshiharu Hiruma et al.
BONE (2013)
The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway
Rina Takamiya et al.
GLYCOBIOLOGY (2013)
Siglec-15 Regulates Osteoclast Differentiation by Modulating RANKL-Induced Phosphatidylinositol 3-Kinase/Akt and Erk Pathways in Association With Signaling Adaptor DAP12
Yusuke Kameda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Impact of Docosahexaenoic Acid on Gene Expression during Osteoclastogenesis in Vitro-A Comprehensive Analysis
Masako Akiyama et al.
NUTRIENTS (2013)
An overview of the regulation of bone remodelling at the cellular level
Jasreen Kular et al.
CLINICAL BIOCHEMISTRY (2012)
Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer
Gabriel A. Rabinovich et al.
IMMUNITY (2012)
Siglec-15 Protein Regulates Formation of Functional Osteoclasts in Concert with DNAX-activating Protein of 12 kDa (DAP12)
Norihiro Ishida-Kitagawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation
Yoshiharu Hiruma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice
Alexander David Barrow et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Siglecs as positive and negative regulators of the immune system
Paul R. Crocker et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk
Wei Zou et al.
MOLECULAR CELL (2008)
Macrophage polarization in tumour progression
Antonio Sica et al.
SEMINARS IN CANCER BIOLOGY (2008)
Siglec-15: an immune system Siglec conserved throughout vertebrate evolution
Takashi Angata et al.
GLYCOBIOLOGY (2007)
Syk, c-Src, the αvβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption
Wei Zou et al.
JOURNAL OF CELL BIOLOGY (2007)
Molecular diversity and evolution of the Siglec family of cell-surface lectins
Takashi Angata
MOLECULAR DIVERSITY (2006)
The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase
A Mócsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
